comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-28 01:34:54 - browse：638

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Why you get paid to donate plasma but not blood

focus

WSS

15 die by electrocution after transformer explodes in northern India

House passes resolution saying Israel isn't a 'racist or apartheid state'

Global cancer cases to surge 77% by 2050, WHO report says

Study: Hearing aids may slow cognitive decline in those at risk

Why you get paid to donate plasma but not blood

Texas Medical Board asked to define abortion emergency exception

hotspot

comprehensive

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

A Theranos scientist

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

New air purifier tech could be key to improving indoor air quality

A look at other Americans who have crossed into North Korea over the years

In age of alternative facts, a scholarly course on calling out crap

Why Novartis is going to walk from its acquisition of MorphoSys

At least 13 dead in Texas as scorching temps continue

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

hotspot

Why you get paid to donate plasma but not blood

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Manchin plays down potential 3rd

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

A single Democrat is willing to weaken Medicare negotiation power

Bernie brings in new pharma CEOs to talk drug prices

explore

hotspot

focus

focus